A single case study on Benign Prostatic Hyperplasia with Dashamoola siddha Taila Uttarbasti

Divyabahen S. Ninama, Harshit Shah, Rajesh Kumar Sharma, Sonal Panchal, Damini Parmar
{"title":"A single case study on Benign Prostatic Hyperplasia with Dashamoola siddha Taila Uttarbasti","authors":"Divyabahen S. Ninama, Harshit Shah, Rajesh Kumar Sharma, Sonal Panchal, Damini Parmar","doi":"10.22270/ajprd.v11i3.1260","DOIUrl":null,"url":null,"abstract":"BPH is major giriatric problem of obstructive uropathic disorders described in ayurveda as one type of Mutraghata.BPH is a non-malignant enlargement of the prostate gland caused by excess growth of prostatic nodules. Histo-pathologically the prevalence of BPH is age dependent, initiate usually after 40 years of age.The age-specific prevalence of benign prostatic hyperplasia has been estimated from autopsy studies to be 8% in the fourth decade of life, 50% in the sixth decade of life, and 80% in the ninth decade of life. BPH is a progressive disease and In Ayurveda, Mutraghata either upper or it is commonly associated with lower urinary tract symptoms such as retension, incomplete voiding, dribbling, hesitancy, incontinence of urine etc. In morden medicine the management of BPH is either by conservative treatment using chemotherapy, hormonal therapy and surgical approach. In this case study, a patient diagnosed with Benign Prostatic Hyperplasia was treated with a Dashamoola siddha TailaUttarbasti 20 ml once daily for three days and then 3 days gap given between two cycles for 21 days. Assessment of patient was done by IPSS (International Prostate Symptom Score) and weight of the prostate and post void residual urine volume. After completion of Uttarbasti treatment significant relief was observed in symptoms.","PeriodicalId":8526,"journal":{"name":"Asian Journal of Pharmaceutical Research and Development","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Pharmaceutical Research and Development","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22270/ajprd.v11i3.1260","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

BPH is major giriatric problem of obstructive uropathic disorders described in ayurveda as one type of Mutraghata.BPH is a non-malignant enlargement of the prostate gland caused by excess growth of prostatic nodules. Histo-pathologically the prevalence of BPH is age dependent, initiate usually after 40 years of age.The age-specific prevalence of benign prostatic hyperplasia has been estimated from autopsy studies to be 8% in the fourth decade of life, 50% in the sixth decade of life, and 80% in the ninth decade of life. BPH is a progressive disease and In Ayurveda, Mutraghata either upper or it is commonly associated with lower urinary tract symptoms such as retension, incomplete voiding, dribbling, hesitancy, incontinence of urine etc. In morden medicine the management of BPH is either by conservative treatment using chemotherapy, hormonal therapy and surgical approach. In this case study, a patient diagnosed with Benign Prostatic Hyperplasia was treated with a Dashamoola siddha TailaUttarbasti 20 ml once daily for three days and then 3 days gap given between two cycles for 21 days. Assessment of patient was done by IPSS (International Prostate Symptom Score) and weight of the prostate and post void residual urine volume. After completion of Uttarbasti treatment significant relief was observed in symptoms.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
使用 Dashamoola siddha Taila Uttarbasti 治疗良性前列腺增生症的单个病例研究
良性前列腺增生症是前列腺结节过度增生引起的前列腺非恶性肿大。组织病理学上,良性前列腺增生症的发病率与年龄有关,通常在 40 岁以后开始发病。根据尸检研究估计,良性前列腺增生症的特定年龄发病率在第四个十年期为 8%,第六个十年期为 50%,第九个十年期为 80%。良性前列腺增生症是一种进展性疾病,在阿育吠陀医学中,Mutraghata 通常伴有上尿路症状或下尿路症状,如尿潴留、排尿不尽、滴沥、迟疑、尿失禁等。在现代医学中,前列腺增生症的治疗方法有化疗、激素治疗和手术治疗等保守疗法。在本病例研究中,一名被诊断为良性前列腺增生症的患者接受了 Dashamoola siddha TailaUttarbasti 20 毫升的治疗,每天一次,连续 3 天,然后在两个周期之间间隔 3 天,共 21 天。通过 IPSS(国际前列腺症状评分)、前列腺重量和排尿后残余尿量对患者进行评估。完成 Uttarbasti 治疗后,症状明显缓解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A Review on Green Chemistry and Its Applications A Review: A Comparative Study of Branded and Generic Anti-Hypertensive Drugs Development and Validation of Fenofibrate in Bulk and Tablets using UV-Spectroscopy: An Anti-Hypercholesterolemic Agent A Review: A Comparative Study of Branded and Generic Anti- Diabetic Drugs Efficacy of Jatyadi Taila Uttarbasti in the Management of Urethral Stricture a Single Case Study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1